EVERNORTH THERAPY LINK
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

EVERNORTH THERAPY LINK Trademark

Serial Number: 99673804

EVERNORTH THERAPY LINK is a trademark filed by Express Scripts Strategic Development, Inc. on February 27, 2026. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Express Scripts Strategic Development, Inc. (10 trademarks)

One Express Way
St. Louis, MO 63121

Entity Type: 03

Trademark Details

Filing Date

February 27, 2026

Registration Date

Not Registered

Goods & Services

Pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits

Specialty pharmacy services for pharmaceuticals, biologics, branded drugs, generics, vaccines, infused medications and ancillary supportive care products; Business consulting and management in the field of clinical trials, namely, providing information management services; Data collection services for business purposes in the nature of extracting, summarizing, analyzing and validating information from medical records in the field of clinical trials management

Providing information on medical services, namely analysis of cell and gene therapy treatment for likely candidates; providing information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare, cell and gene therapies and treatments, and healthcare and treatment demographics, costs, and outcomes; providing life sciences information; recruitment and selection of clinical trial participants

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 7, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jul 7, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jul 7, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 25, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 27, 2026 MAFR
NEW APPLICATION ENTERED
Feb 27, 2026 NWAP